Suzuki K, Mori A, Lavaroni S, Miyagi E, Ulianich L, Katoh R, Kawaoi A, Kohn L D
Department of Pathology, Yamanashi Medical University, Nakakoma, Japan.
Thyroid. 1999 Apr;9(4):319-31. doi: 10.1089/thy.1999.9.319.
We used in situ hybridization to evaluate thyroid transcription factor-1 (TTF-1) RNA expression in individual follicles and related this to thyroglobulin (Tg) synthesis in vivo, as estimated by immunohistochemical analysis. We studied the thyroids of Wistar rats treated with thyroxine (T4) or propylthiouracil (PTU), each of which modulates TSH levels, but affects follicular function and Tg accumulation in the follicular lumen very differently. We show that TTF-1 RNA levels in vivo correlate directly with an increase in the cytoplasmic accumulation of Tg within the cells of individual follicles. Because TTF-1 increases Tg gene expression, RNA levels, and protein synthesis in thyroid cell cultures and because there is no correlation with TSH-increased Tg degradation within the follicular lumen, the increased cytoplasmic accumulation of Tg in vivo is interpreted to reflect TTF-1-increased Tg synthesis. Increases in serum TSH levels in the PTU or T4 treated animals did not always correlate with increases in this measure of increased Tg synthesis; and TSH levels did not always correlate with changes in TTF-1 RNA levels that would be expected to accompany increased Tg synthesis. As one possibility, this suggested there might be a hitherto unrecognized suppressor of TTF-1 RNA levels and TSH-induced Tg synthesis in individual follicles. The immunohistochemical data suggested that this suppressor might be follicular Tg itself. Supporting this possibility, we show that physiological concentrations of highly purified 19S follicular Tg decrease TTF-1 RNA levels in rat FRTL-5 thyroid cells and inhibit the action of TSH to increase Tg synthesis. We therefore suggest that follicular Tg is a feedback autoregulator of thyroid function that can counterregulate TSH actions on thyroid function in vivo and in thyroid cells in culture. We suggest this phenomenon contributes to follicular heterogeneity in vivo.
我们采用原位杂交技术评估单个滤泡中甲状腺转录因子-1(TTF-1)RNA的表达情况,并将其与体内甲状腺球蛋白(Tg)的合成相关联,后者通过免疫组织化学分析进行估算。我们研究了用甲状腺素(T4)或丙硫氧嘧啶(PTU)处理的Wistar大鼠的甲状腺,这两种药物均可调节促甲状腺激素(TSH)水平,但对滤泡功能以及滤泡腔内Tg积聚的影响却大不相同。我们发现,体内TTF-1 RNA水平与单个滤泡细胞内Tg胞质积聚的增加直接相关。由于TTF-1可增加甲状腺细胞培养物中Tg基因的表达、RNA水平及蛋白质合成,且与滤泡腔内TSH增加的Tg降解无关,因此体内Tg胞质积聚的增加被认为反映了TTF-1增加的Tg合成。PTU或T4处理动物的血清TSH水平升高并不总是与这种Tg合成增加的指标升高相关;TSH水平也并不总是与预期伴随Tg合成增加的TTF-1 RNA水平变化相关。一种可能性是,这表明可能存在一种迄今未被认识的抑制单个滤泡中TTF-1 RNA水平及TSH诱导的Tg合成的物质。免疫组织化学数据表明,这种抑制物可能是滤泡Tg本身。支持这一可能性的是,我们发现生理浓度的高度纯化的19S滤泡Tg可降低大鼠FRTL-5甲状腺细胞中的TTF-1 RNA水平,并抑制TSH增加Tg合成的作用。因此,我们认为滤泡Tg是甲状腺功能的一种反馈自动调节因子,可在体内及培养的甲状腺细胞中对抗TSH对甲状腺功能的作用。我们认为这种现象导致了体内滤泡的异质性。